Audentes Therapeutics, Inc. (BOLD)
Jul 16 6:55pm Add BOLD to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
BOLD News Stream
All News Types
Barron's Commentary Debt Offering Downgrade Earnings IPOs New Coverage (Bearish) New Coverage (Bullish) New Coverage (Neutral) Product News PT Lowered PT Raised PT Set (Bullish) PT Set (Neutral) Rating Reiterated (Bullish) Stock Offering Upgrade
Loading, please wait...
View All BOLD News
Audentes Therapeutics, Inc. (BOLD) Company Bio
Audentes Therapeutics, Inc., a biotechnology company, focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects in the United States. The company was founded in 2012 and is based in San Francisco, California.
BOLD Price/Volume Stats
Page generated in 0.4183 seconds.